URGN
UroGen Pharma Ltd
43.20$
-0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.4% | 98.7% | 95.6% | 98.6% | 98.7% | 73.4% | 94.8% | 95.5% | 95.1% | 94.9% | 96.6% | 92.8% | |
| 88.8% | 92.7% | 92.7% | 49.0% | 97.8% | 24.6% | 43.3% | 37.0% | 40.9% | 53.3% | 60.2% | 55.2% | |
| 88.8% | 92.7% | 92.7% | 96.6% | 97.8% | 72.7% | 83.6% | 74.4% | 73.7% | 76.8% | 82.8% | 60.1% | |
| – | – | 0.4% | 0.3% | – | – | 5.8% | 9.8% | 9.4% | 8.7% | 7.1% | 16.5% | |
| – | – | 0.5% | 0.4% | – | – | 1.6% | 4.0% | 3.2% | 3.2% | 3.2% | 8.2% | |
| 1.6% | 1.3% | 3.2% | 1.1% | 0.9% | 2.3% | 3.4% | 1.6% | 1.0% | – | – | – | |
| 20.4% | 11.5% | 29.3% | 9.3% | 13.0% | 10.9% | 21.0% | 93.0% | 165.9% | 136.6% | 103.1% | 152.6% | |
| 20.4% | 11.5% | 13.6% | 9.3% | 13.0% | 9.6% | 17.6% | 18.7% | 17.6% | 17.5% | 16.1% | 23.2% | |
| – | – | – | – | – | – | 1.5% | 2.8% | 0.7% | 0.5% | 0.5% | – | |
| 11.8% | 8.8% | 8.2% | 3.8% | 4.1% | 2.3% | 2.7% | 4.8% | 4.1% | 3.7% | 3.8% | 6.1% | |
| – | 4.5% | 15.7% | – | – | – | – | – | 71.9% | 55.3% | 42.6% | 61.0% | |
| 79.6% | 88.5% | 70.7% | 90.7% | 87.0% | 89.1% | 79.0% | 7.0% | -65.9% | -36.6% | -3.1% | -52.6% | |
| -288.7% | -130.3% | -118.0% | -62.5% | -118.6% | -112.7% | -292.2% | -390.3% | -425.5% | -381.0% | -282.2% | -478.8% | |
| 52.8% | 11.9% | 51.9% | 12.9% | 15.2% | 10.1% | 17.9% | 18.7% | 16.8% | 16.2% | 15.0% | 24.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.